The Ohio State University Wexner Medical Center First in Midwest to Use Novel Device to Treat Heart Rhythm Disorder
October 26, 2026
The Ohio State University Wexner Medical Center is the first center in the Midwest to enroll and treat a patient in a clinical trial evaluating a novel device for ventricular tachycardia, a potentially life-threatening heart rhythm disorder. The investigational technology combines heart mapping, treatment and assessment functions in a single catheter and may help improve the efficiency and effectiveness of cardiac ablation procedures.



